An Efficient Procedure for Calculating Sample Size Through Statistical Simulations

ABSTRACT While planning clinical trials, when simple formulas are unavailable to calculate sample size, statistical simulations are used instead. However, one has to spend much computation time obtaining adequately precise and accurate simulated sample size estimates, especially when there are many scenarios for the planning and/or the specified statistical method is complicated. In this article, we summarize the theoretical aspect of statistical simulation-based sample size calculation. Then, we propose a new simulation procedure for sample size calculation by fitting the probit model to simulation result data. From the theoretical and simulation-based evaluations, it is suggested that the proposed simulation procedure provide more efficient and accurate sample size estimates than ordinary algorithm-based simulation procedure especially when estimated sample sizes are moderate to large, therefore it would help to dramatically reduce the computational time required to conduct clinical trial simulations.

[1]  Steven A Julious,et al.  Tutorial in biostatistics: sample sizes for parallel group clinical trials with binary data , 2012, Statistics in medicine.

[2]  J. Babb,et al.  Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control , 2005, Statistics in medicine.

[3]  Mark Chang,et al.  Adaptive Design Methods in Clinical Trials, Second Edition , 2011 .

[4]  E. Pulkstenis,et al.  Sample Size and Power of Survival Trials in Group Sequential Design With Delayed Treatment Effect , 2016 .

[5]  S. Julious Sample sizes for clinical trials with Normal data , 2004, Statistics in medicine.

[6]  D. Rubin,et al.  Multiple Imputation for Nonresponse in Surveys , 1989 .

[7]  Sue-Jane Wang,et al.  Modification of Sample Size in Group Sequential Clinical Trials , 1999, Biometrics.

[8]  Haiyuan Zhu Sample Size Calculation for Comparing Two Poisson or Negative Binomial Rates in Noninferiority or Equivalence Trials , 2017 .

[9]  Computational aspects of probit model , 2001 .

[10]  Bohdana Ratitch,et al.  Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models , 2013, Pharmaceutical statistics.

[11]  Frank Bretz,et al.  Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts , 2006, Biometrical journal. Biometrische Zeitschrift.

[12]  Mark Chang,et al.  Adaptive Design Methods in Clinical Trials , 2006 .

[13]  D. Schoenfeld,et al.  Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.

[14]  Patrick Royston,et al.  The design of simulation studies in medical statistics , 2006, Statistics in medicine.

[15]  Jeff Maca,et al.  Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples , 2006 .

[16]  D. DeMets,et al.  Increasing the sample size when the unblinded interim result is promising , 2004, Statistics in medicine.

[17]  P. Thall,et al.  Hierarchical Bayesian approaches to phase II trials in diseases with multiple subtypes , 2003, Statistics in medicine.

[18]  D. Cox Tests of Separate Families of Hypotheses , 1961 .